Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Completed × INDIV × Microbial Collagenase × Clear all

Phase

Status

Sponsor Class

INDUSTRY 7 OTHER 5 INDIV 2

Study Type

Interventional 2

Sponsor

Conditions

Interventions

Proflavine 3 Microbial Collagenase 2 sargramostim 1 pembrolizumab 1 pegfilgrastim 1 macimorelin 1 keyhole-limpet hemocyanin 1 Sodium Chloride 1 Sirolimus 1 Peptides 1 Monatide (IMS 3015) 1 Ipilimumab 1 Gemcitabine 1 Everolimus 1 Bimatoprost 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02249052 2017-02-23

Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed

19 enrolled 11 charts

Lipoma

NCT01613313 2016-10-06

A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed

14 enrolled 8 charts

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡